Results of operations, financial position, assets and liabilities

The main acquisition-related effect on operational efficiency was the full-year consolidation of APP Pharmaceuticals, one of the leading manufacturers of IV drugs in North America. APP Pharmaceuticals achieved sales of US$ 889 million in 2009.

Continue reading:
Results of operations


My Annual Report

Your page has been added successfully

Link für Popup